Drug delivery, formulation

(Image: Getty/eaglesky)

CRO market to reach $44.4bn by 2021

By Melissa Fassbender

The global contract research organization (CRO) market is forecasted to grow 12% year-on-year through 2021 – led by IQVIA with 12.4% of the market share.

(Image: Getty/oatwa)

RxCelerate acquires specialist bioanalytical CRO

By Melissa Fassbender

UK-headquartered RxCelerate has acquired the specialist bioanalytical contract research organization Total Scientific – increasing its staff to 37 following its expansion stateside in November 2017.

(Image: Getty/denisik11)

Letter to the editor

Sizing up: Does CRO consolidation leave space for smaller firms?

By Melissa Fassbender

A continued need for specialized services and expertise will keep smaller firms in business – though many have forecasted the “death of small- to mid-sized CROs” as the industry continues to consolidate, say experts.

(Image: Getty/TomasSereda)

What to expect at DCAT Week 2018

By Melissa Fassbender

This year’s DCAT Week will focus on innovation in the pharmaceutical industry, with two new Executive Insights programs.

(Image: Getty/Image Source)

Charles River bolsters global biologics business

By Melissa Fassbender

Charles River has made several expansions across the globe, including a new, 73,000 square-foot facility in Wayne, PA, which doubles its laboratory footprint in the state.

(Image: Getty/NikiLitov)

Update

PE-backed CMO expands syringe filling capabilities

By Melissa Fassbender

Grand River Aseptic Manufacturing (GRAM) has purchased a new syringe filler to help meet "the rising demand" for parenteral development and manufacturing services.

(Image: Getty/martince2)

SCOPE 2018

A CRO monopoly? Sponsors frustrated with lack of options

By Melissa Fassbender

With fewer global mid-sized contract research organizations (CRO) through consolidation, some stakeholders are expressing concern that the industry could become a monopoly – “we may be getting there,” one expert said.

(Image: iStock/daizuoxin)

News in brief

BioDuro teams up with API developer Porton

By Melissa Fassbender

The San Diego-CA-based contract research, development, and manufacturing organization (CDMO), BioDuro, has announced a cooperation agreement with Porton Pharma Solutions.

(Image: iStock/thomas-bethge)

Reports revisited: What we learned this year

By Melissa Fassbender

Outsourcing models examined, market shifts scrutinized, and trial tribulations analyzed – take a look back at some of the top reports published in 2017.

(Image: Getty/marchmeena29)

4 trends driving industry priorities in 2018

By Melissa Fassbender

Commercial transformation could reach new heights in 2018, says inVentiv – as new expectations (and possibilities) reshape traditional models.

(Image: Getty/tortoon)

Guest article

Looking over the horizon: 2018 and beyond

By Doug Peddicord, PhD, executive director of the Association of Clinical Research Organizations (ACRO)

As the great Yogi Berra once said, “It’s tough to make predictions, especially about the future.” But it is safe to say that after a year of considerable consolidation and change, the CRO industry anticipates continuing and potentially rapid evolution...

(Image: Getty/RomoloTavani)

Guest article

3 global trends driving transformations in healthcare product development

By Sudip S. Parikh, PhD, senior vice president & managing director, DIA Americas

The healthcare product development ecosystem is undergoing massive changes. Significant transformations are underway in how drugs and medical devices are researched, developed, manufactured, and approved.

GettyImages/Feverpitched

UK drug development firm RxCelerate expands in US

By Flora Southey

Contract drug developer RxCelerate has opened an office in Massachusetts to expand its medicinal chemistry, antibody discovery, and preclinical safety services throughout North America.

Follow us

Related News

Product Innovations

Promotional Features